| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0002 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |